SCHEMBL3503301

SCHEMBL3503301

Brc1ccns1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7623308 0.63
SCHEMBL275814 0.62
SCHEMBL6635080 0.62
SCHEMBL128951 0.62
SCHEMBL407607 0.62
SCHEMBL16084111 0.62
SCHEMBL275815 0.62
SCHEMBL2010457 0.62
Hydrochloric Acid SCHEMBL25190315 0.61
SCHEMBL7171043 0.61 EP300 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2743269-B1 PIM KINASE INHIBITOR, PREPARATION METHOD AND USE THEREOF IN DRUG PREPARATION JIKAI BIOSCIENCES INC (CN) 2018-09-26 EP claimed
CN-102924444-B PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy SHANGHAI JIKAI MEDICAL TECHNOLOGY CO LTD 2015-07-08 CN claimed
US-8969584-B2 PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof Jikai Biosciences, Inc. (CN) 2015-03-03 US claimed
EP-2743269-A1 PIM KINASE INHIBITOR, PREPARATION METHOD AND USE THEREOF IN DRUG PREPARATION Jikai Biosciences Inc. (CN) 2014-06-18 EP claimed
US-20140162998-A1 PIM KINASE INHIBITORS AND PREPARATION METHODS AND USE IN MEDICINAL MANUFACTURE THEREOF Jikai Biosciences, Inc. (CN) 2014-06-12 US claimed
CN-102924444-A PIM kinase inhibitor, preparation method thereof, and application thereof in pharmacy SHANGHAI JIKAI MEDICAL TECHNOLOGY CO LTD 2013-02-13 CN claimed
CN-122029158-A EGFR inhibitors 缆图药品公司 2026-05-12 CN disclosed
US-12485169-B2 Compounds Grey Wolf Therapeutics Limited (GB) 2025-12-02 US disclosed
EP-4642778-A1 LSD1 MODULATORS Recursion Pharmaceuticals, Inc. (US) 2025-11-05 EP disclosed
EP-4638436-A1 PRMT5 INHIBITORS AND USES THEREOF GILEAD SCIENCES, INC. (US) 2025-10-29 EP disclosed
EP-4584259-A1 CK1ALPHA AND DUAL CK1ALPHA / GSPT1 DEGRADING COMPOUNDS Innovo Therapeutics, Inc. (US) 2025-07-16 EP disclosed
CN-120025279-A Compounds capable of modulating endoplasmic reticulum aminopeptidase 1 格雷沃尔夫治疗有限公司 2025-05-23 CN disclosed
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 US disclosed
US-6235750-B1 NITRIC OXIDE SYNTHASE INHIBITOR PFIZER INC 2001-05-22 US disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 WO disclosed
CN-1239952-A 6-phenylpyridyl-2-amine derivatives useful as NOS inhibitors PFIZER (US) 1999-12-29 CN disclosed
EP-0946512-A1 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS PFIZER INC. (US) 1999-10-06 EP disclosed
WO-1998024766-A1 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS PFIZER INC. (US) 1998-06-11 WO disclosed
US-4005202-A 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity SYNTEX (U.S.A.) INC. (US) 1977-01-25 US disclosed
US-3935209-A 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity SYNTEX (U.S.A.) INC. (US) 1976-01-27 US disclosed